Genome-wide search for breast cancer linkage in large Icelandic non-BRCA1/2 families
Authors:
- Adalgeir ArasonAAAdalgeir Arason
- Haukur GunnarssonHGHaukur Gunnarsson
- Gudrun JohannesdottirGJGudrun Johannesdottir
- Kristjan JonassonKJKristjan Jonasson
- Pär-Ola BendahlPBPär-Ola Bendahl
- Elizabeth M GillandersEGElizabeth M Gillanders
- Bjarni A AgnarssonBABjarni A Agnarsson
- Göran JönssonGöran Jönsson
- Katri PylkäsKPKatri Pylkäs
- Aki MustonenAMAki Mustonen
- Tuomas HeikkinenTHTuomas Heikkinen
- Kristiina AittomäkiKAKristiina Aittomäki
Open Access
- 16 July 2010
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research
- Vol. 12 (4) , R50
Abstract
Introduction: A significant proportion of high-risk breast cancer families are not explained by mutations in known genes. Recent genome-wide searches (GWS) have not revealed any single major locus reminiscent of BRCA1 and BRCA2, indicating that still unidentified genes may explain relatively few families each or interact in a way obscure to linkage analyses. This has drawn attention to possible benefits of studying populations where genetic heterogeneity might be reduced. We thus performed a GWS for linkage on nine Icelandic multiple-case non-BRCA1/2 families of desirable size for mapping highly penetrant loci. To follow up suggestive loci, an additional 13 families from other Nordic countries were genotyped for selected markers. Methods: GWS was performed using 811 microsatellite markers providing about five centiMorgan (cM) resolution. Multipoint logarithm of odds (LOD) scores were calculated using parametric and nonparametric methods. For selected markers and cases, tumour tissue was compared to normal tissue to look for allelic loss indicative of a tumour suppressor gene. Results: The three highest signals were located at chromosomes 6q, 2p and 14q. One family contributed suggestive LOD scores (LOD 2.63 to 3.03, dominant model) at all these regions, without consistent evidence of a tumour suppressor gene. Haplotypes in nine affected family members mapped the loci to 2p23.2 to p21, 6q14.2 to q23.2 and 14q21.3 to q24.3. No evidence of a highly penetrant locus was found among the remaining families. The heterogeneity LOD (HLOD) at the 6q, 2p and 14q loci in all families was 3.27, 1.66 and 1.24, respectively. The subset of 13 Nordic families showed supportive HLODs at chromosome 6q (ranging from 0.34 to 1.37 by country subset). The 2p and 14q loci overlap with regions indicated by large families in previous GWS studies of breast cancer. Conclusions: Chromosomes 2p, 6q and 14q are candidate sites for genes contributing together to high breast cancer risk. A polygenic model is supported, suggesting the joint effect of genes in contributing to breast cancer risk to be rather common in non-BRCA1/2 families. For genetic counselling it would seem important to resolve the mode of genetic interaction.Keywords
This publication has 38 references indexed in Scilit:
- Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility geneNature Genetics, 2010
- Genome-wide Linkage Scan Reveals Three Putative Breast-Cancer-Susceptibility LociThe American Journal of Human Genetics, 2009
- A second-generation combined linkage–physical map of the human genome: Table 1.Genome Research, 2007
- Genomewide high-density SNP linkage analysis of non-BRCA1/2 breast cancer families identifies various candidate regions and has greater power than microsatellite studiesBMC Genomics, 2007
- A genome wide linkage search for breast cancer susceptibility genesGenes, Chromosomes and Cancer, 2006
- The BOADICEA model of genetic susceptibility to breast and ovarian cancerBritish Journal of Cancer, 2004
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesThe American Journal of Human Genetics, 1998
- Strong indication for a breast cancer susceptibility gene on chromosome 8p12-p22: linkage analysis in German breast cancer familiesOncogene, 1997
- Genetic dissection of complex traits: guidelines for interpreting and reporting linkage resultsNature Genetics, 1995
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences, 1971